Structural and Electronic Factors Governing the Action of Anticonvulsants
A selection of eighteen anticonvulsant drug molecules has been subjected to both geometrical analysis and atomic charge calculation to search for a link between structure and activity. A significant consequence of this study is the discovery of a fused 5,6,7 chemical ring system which suggests that these drugs may interact with a receptor site which is its topological complement. Molecular orbital calculations support the observation that anticonvulsant activity appears to be related to the net atomic charge on a specific carbon atom which is central to the fused ring system.
Keywords: Anticonvulsant, lamotrigine, epilepsy, charge calculation.
2 Hoffmann R. An Extended Hückel Theory 1 Hydrocarbons. J. Med. Chem. 1963; 39:1397-1492.
3. Pople JA, Santry DP and Segal GA. Approximate Self-consistent Molecular Orbital Theory 1. Invariant Procedures. J. Chem. Phys. 1965; 43:S129-135.
4. People JA and Segal GA. Approximate Self-Consistent Molecular Orbital Theory. 111. CNDO Results for AB2 and AB3 Systems. J. Chem. Phys.1966; 44:3289.
5. Camerman A and Camerman N. Stereochemical similarities in chemically different antiepileptic drugs. Adv. Neurol. 1980; 27:223-235.
6. Camerman A and Camerman N. On the Crystallography and Stereochemistry of Antiepileptic Drugs. Acta. Crystallogr. 1981; B37:1677-1679.
7. Camerman N and Camerman A. The Stereochemical Basis of Anticonvulsant Drug Action. Mol. Pharmacol. 1971; 7:406-421.
8. Jones GL and Woodbury M. Antiepileptic Drugs (Wood, Pendry and Pippenger, eds.) Raven N.Y. 1982.
9. Steward J. “MOPAC” Quantum Chemistry Program Exchange, Dept. Chem., University of Indiana, USA. 1986.
10. Dewar MJS and Thiel WJ. Ground states of molecules. The MNDO method. Approximations and parameters. 38. Am. Chem. Soc, 1977; 99:4899-4907.
11. Janes RW, Lisgarten JN and Palmer RA. Structure of lamotrigine methanol solvate 3,5 diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine methanol, a novel anticonvulsant drug. Acta. Crystallogr. 1989; C45:129-132.
12. Davies E K. CHEM-X, Chemical Design Ltd. Oxford.
13. Hester JB, Rudzie AD and Veldkamp W. Pyrrolo[3,2,1-jk] [1,4] benzodiazepines and pyrrolo[1,2,3-ef] [1,5] benzodiazepines which have central nervous system activity. J.Med. Chem. 1970; 15:827-835.
14. Lisgarten JN and Palmer RA. The Structure of (1,2-Benzisoxazol-3-yl) methanesulfonamide: A Novel Antiepileptic Drug. Acta. Crystallogr. 1988; C44:2013-2016.
15. Lisgarten JN, Saldanha JW and Palmer RA. Crystal and molecular structure of 5-carbamyl-5H-dibenzo- [b, f] azepine J. Cryst. Spect. Res. 1989; 19:641-649.
16. Camerman A and Camerman N. The stereochemical basis of anticonvulsant drug action. I. The crystal and molecular structure of diphenylhydantoin, anoncentrosymmetric structure solved by symbolic addition. Acta. Crystallogr, 1971; B27:2205-2211.
17. Camerman A and Camerman N. Stereochemical basis of anticonvulsant drug action. II. Molecular structure of diazepam. J. Am. Chem. Soc. 1972; 94:268-272.
18. Lisgarten JN and Palmer RA. Structure of 9-(2-fluorobenzyl)-6-methylamino-9H-purine hydrochloride, a novel anticonvulsant. Acta. Crystallogr. 1988; C44:654-657.
19. Lisgarten JN, Saldanha JW and Palmer RA. The structure of 10,11-dihydro10-hydroxy-5H-dibenz [b, f] azepine -5-carboxamide, an anticonvulsant drug molecule. Acta. Crystallogr. 1989; C45:656-658.
20. Codding PW, Lee TA and Richardson J F. Cyheptamide and 3-hydroxy-3-Phenacyloxindole structural similarity to diphenylhydantoin as the basis for anticonvulsant activity. J. Med. Chem. 1984; 27:649-654.
21. Wünderlich H. Structure of 1-methyl-5,5-diethylbarbituric acid. Acta. Crystallogr. 1973; B24:168-172.
22. Lisgarten J N and Palmer RA. The structure of methoin: an anticonvulsant drug. Acta. Crystallogr. 1980; B36:2345-2349.
23. Gilli G, Bertolasi V, Sacerdoti M and Borea P A. 7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one (nitrazepam). Acta. Crystallogr. 1977; B33:2664-2667.
24. Gilli G, Bertolasi V, Sacerdoti M and Borea PA. The crystal and molecular structure of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam). Acta. Crystallogr. 1978; B34:2826-2829.
25. Williams P. Polymorphism of phenobarbitone: the crystal structure of 5-ethyl-5-phenylbarbituric acid monohydrate. Acta. Crystallogr. 1973; B27:1572-1579
26. Lisgarten JN and Palmer R A. Structure of 1- [6 –(2-chlorophenyl)-3-piperidin-4-ol, an anticonvulsant drug. Acta. Crystallogr. 1989; C45:102-104.
27. Yeats DGR and Palmer R A. The crystal structure of primidone. Acta. Crystallogr. 1975; B31:1077-1082.
28. Lisgarten J N and Palmer R A. The structure of stiripentol:4,4-dimethyl-1-(3,4-methylenedioxyphenyl)-1-pentene-3-ol- a novel antiepileptic drug. Acta Crystallogr. 1988; C44:1992-1994.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).